AMGEN INC — Form D/A

AMGEN INC of Thousand Oaks, CA, a company, filed a Form D amendment with the SEC on 2015-01-23. The offering totals $2.5B. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
David A BaltimoreDirectorThousand Oaks, CA
Francois J de CarbonnelDirectorThousand Oaks, CA
Robert A EckertDirectorThousand Oaks, CA
Greg C GarlandDirectorThousand Oaks, CA
Rebecca M HendersonDirectorThousand Oaks, CA
Tyler C JacksDirectorThousand Oaks, CA
R. Sanders WilliamsDirectorSouth San Francisco, CA
Madhavan A BalachandranExecutive OfficerThousand Oaks, CA
Sean E HarperExecutive OfficerThousand Oaks, CA
Anthony C HooperExecutive OfficerThousand Oaks, CA
David W MelineExecutive OfficerThousand Oaks, CA
Cynthia M PattonExecutive OfficerThousand Oaks, CA
David M PiacquadExecutive OfficerThousand Oaks, CA
Stuart A TrossExecutive OfficerThousand Oaks, CA
Michael A KellyExecutive OfficerPrinceton, NJ
Roger M PerlmutterExecutive OfficerHayward, CA
Gilbert S OmennDirectorNorcross, GA
David JW BaltimoreDirectorThousand Oaks, CA
Scott A TrossExecutive OfficerThousand Oaks, CA
Thomas JW DittrichExecutive OfficerThousand Oaks, CA
Rebecca A HendersonDirectorThousand Oaks, CA
J. Paul ReasonDirectorThousand Oaks, CA
Ronald D SugarDirectorThousand Oaks, CA
Vance J CoffmanDirectorThousand Oaks, CA
Jonathan M PeacockExecutive OfficerThousand Oaks, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2014-01-29D/A$2.5B
2013-02-04D/A$2.5B
2012-02-29D/A$2.5B
2011-03-14D$2.3B

More